quite curious. Amp 945 has ODD status in two areas - pancreatic cancer and lung fibrosis - I’m thinking IND is to cover clinical trials but they’ve already commenced and the drug is safe and tolerable (with promising signs of efficacy) so this ought to be an administrative process. I wonder if there’s some details they need to address. I guess this can run in parallel but I’m not an expert.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.3¢ |
Change
-0.008(3.13%) |
Mkt cap ! $113.1M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $307.4K | 1.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 885969 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 317712 | 11 |
View Market Depth
| Last trade - 10.50am 01/08/2025 (20 minute delay) ? |
| ATX (ASX) Chart |